A Novel Gene Delivery System for Mammalian Cells

Anticancer Research

Volumn 24, Issue 2 A, 2004, Pages 483-488

  Gibson, Brian ^a   Duffy, Angela M ^a   Fogerite, Susan Gould ^b   Krause Elsmore, Sara ^b   Lu, Ruying ^b   Shang, Gaofeng ^b   Chen, Zi Wei ^b   Mannino, Raphael J ^b   Bouchier Hayes, David J ^a   Harmey, Judith H ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cochleate; Gene therapy; Macrophage; Transgene; Tumour cell

Indexed keywords

GREEN FLUORESCENT PROTEIN; LIPID; PLASMID DNA; RHODAMINE; RHODAMINE COCHLEATE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL CELL; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; GENE DELIVERY SYSTEM; GENETIC DISORDER; HUMAN; HUMAN CELL; HYBRIDOMA; IN VITRO STUDY; IN VIVO STUDY; LIPID ANALYSIS; MACROPHAGE ACTIVATION; MAMMAL CELL; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; LIPID BILAYERS; LUMINESCENT PROTEINS; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PLASMIDS; RHODAMINES; TRANSFECTION; TRANSGENES;

EID: 2442494275     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K and Isner JM: Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154: 355-363, 1999.
2. Dani SU: The challenge of vector development in gene therapy. Braz J Med Biol Res 32: 133-145, 1999.
3. Luo D and Saltzman WM: Synthetic DNA delivery systems. Nat Biotechnol 18(1): 33-7, 2000.
4. Griesenbach U, Ferrari S, Geddes DM and Alton EW: Gene therapy progress and prospects: cystic fibrosis. Gene Ther 9(20): 1344-50, 2002.
5. Mah C, Byrne BJ and Flotte TR: Virus-based gene delivery systems. Clin Pharmacokinet 41(12): 901-11, 2002.
6. Niidome T and Huang L: Gene therapy progress and prospects: nonviral vectors. Gene Ther 9(24): 1647-52, 2002.
7. Cemazar M, Sersa G, Wilson J, Tozer GM, Hart SL, Grosel A and Dachs GU: Effective gene transfer to solid tumours using different nonviral gene delivery techniques: Electroporation, liposomes and integrin-targeted vector. Cancer Gene Ther 9: 399-406, 2002.
8. Santangelo R, Paderu P, Delmas G, Chen ZW, Mannino R, Zarif L and Perlin DS: Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob Agents Chemother 44: 2356-2360, 2000.
9. Gould-Fogerite S, Kheiri M, Zhang F and Mannino RJ: Cochleate delivery vehicles: applications in vaccine delivery. J Liposome Res Vol 10(4): 339-358, 2000.
10. Zarif L, Graybill J, Perlin D and Mannino R: Cochleates: new lipid-based drug delivery system. J Liposome Res 10(4): 523-538, 2000.
11. Mannino RJ and Gould-Fogerite S: Antigen cochleate preparations for oral and systemic vaccination. In: New Generation Vaccines (Levine MM, Woodrow GC, Kaper JB and Cobon GS eds) Marcel Dekker Inc 2000 pp229-237.
12. Zarif L and Mannino RJ: Cochleates. Lipid-based vehicles for gene delivery-concept, achievements and future development. In: Cancer Gene Therapy: Past Achievements and Future Challenges (edited by Habib) Kluwer Academic/ Plenum Publishers, New York. 2000 pp83-93.
13. Montal M: Electrostatic attraction at the core of membrane fusion. FEBS Lett 447(2-3): 129-30, 1999.
14. Burgoyne RD and Morgan A: Ca2+ and secretory-vesicle dynamics. Trends Neurosci 18(4): 191-6, 1995.
15. Brunger AT: Structural insights into the molecular mechanism of calcium-dependent vesicle-membrane fusion. Curr Opin Struct Biol 11(2): 163-73, 2001.
16. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T and Wallace J: United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77: 1-10, 1998.
17. Harmey J, Dimitriadis E, Kay E, Redmond HP and Bouchier-Hayes D: Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor b-1. Ann Surg Oncol 5: 271-8, 1998.
18. Horwood NJ, Smith C, Andreakos E, Quattrocchi E, Brennan FM, Feldmann M and Foxwell BMJ: High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets. Arthritis Res 4: S215-S225 2002.
19. Segarra I, Movshin DA and Zarif L: Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid-based delivery system. J Pharm Sci 91: 1827-1837, 2002.
20. Gould-Fogerite S, Kheiri M, Zhang F and Mannino RJ: Cochleate delivery vehicles: applications in vaccine delivery. J Liposome Res 10: 339-358, 2000.
21. Parker GA, Peng B, He M, Gould-Fogerite S, Chou CC and Raveche ES: In vivo and in vitro anti-proliferatiuve effects of antisense interleukin 10 oligonucleotides. Methods Enzymol 314: 411-429, 2000.